AWM
CNMD icon

Abound Wealth Management’s CONMED CNMD Stock Holding History

Abound Wealth Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66 Hold
2
– – ﹤0.01% 1336
2026
Q1 		$71 Hold
2
– – ﹤0.01% 1459
2025
Q4 		$82 Hold
2
– – ﹤0.01% 1402
2025
Q3 		$95 Hold
2
– – ﹤0.01% 1314
2025
Q2 		$105 Hold
2
– – ﹤0.01% 1247
2025
Q1 		$121 Sell
2
-1
-33% -$64 ﹤0.01% 1183
2024
Q4 		$206 Hold
3
– – ﹤0.01% 1055
2024
Q3 		$216 Hold
3
– – ﹤0.01% 1114
2024
Q2 		$208 Sell
3
-1
-25% -$73 ﹤0.01% 1100
2024
Q1 		$321 Hold
4
– – ﹤0.01% 1101
2023
Q4 		$439 Buy
4
+2
+100% +$207 ﹤0.01% 976
2023
Q3 		$202 Hold
2
– – ﹤0.01% 1102
2023
Q2 		$272 Buy
+2
New +$244 ﹤0.01% 1093

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Abound Wealth Management's CNMD Position: Q2 2026 in Review

Abound Wealth Management held its CONMED (CNMD) position steady in Q2 2026 at 2 shares worth $66. The position accounts for ﹤0.01% of the portfolio, ranked #1336.

Abound Wealth Management first reported a position in CNMD in Q2 2023 and has held it in 13 quarters since. The position peaked at $439 in Q4 2023. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Abound Wealth Management held 2 shares of CONMED worth $66 as of Q2 2026.
  • Abound Wealth Management left its CONMED share count unchanged in Q2 2026.
  • CONMED made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #1336 holding.
  • Abound Wealth Management first reported a position in CONMED in Q2 2023 and has held it in 13 quarters since.
  • Abound Wealth Management's CONMED position peaked at $439 in Q4 2023.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.